Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Merck
Daiichi Sankyo
Citi
McKesson
Novartis
Healthtrust
Teva
Queensland Health
Johnson and Johnson

Generated: August 17, 2017

DrugPatentWatch Database Preview

GLYCOPYRROLATE Drug Profile

« Back to Dashboard

What is the patent landscape for Glycopyrrolate, and what generic Glycopyrrolate alternatives are available?

Glycopyrrolate is a drug marketed by Watson Labs, Appco Pharma Llc, Natco Pharma Ltd, Vintage Pharms, Rising Pharms Inc, Nexgen Pharma, Luitpold, Hikma Intl Pharms, Somerset Theraps Llc, Sun Pharm Inds Ltd, Dr Reddys Labs Ltd, Par Pharm, Hikma Farmaceutica, Epic Pharma Llc, Teva Parenteral, Amneal Pharms Co, Abraxis Pharm, Aurolife Pharma Llc, Santos Biotech, Hospira, and Leading Pharma Llc. and is included in twenty-six NDAs.

The generic ingredient in GLYCOPYRROLATE is glycopyrrolate. There are fifteen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the glycopyrrolate profile page.

Summary for Tradename: GLYCOPYRROLATE

Patents:0
Applicants:21
NDAs:26
Suppliers / Packagers: see list27
Bulk Api Vendors: see list50
Clinical Trials: see list93
Patent Applications: see list2,082
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:GLYCOPYRROLATE at DailyMed

Pharmacology for Tradename: GLYCOPYRROLATE

Drug ClassAnticholinergic
Mechanism of ActionCholinergic Antagonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
GLYCOPYRROLATE
glycopyrrolate
TABLET;ORAL086178-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Parenteral
GLYCOPYRROLATE
glycopyrrolate
INJECTABLE;INJECTION081169-001Sep 10, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe
Santos Biotech
GLYCOPYRROLATE
glycopyrrolate
TABLET;ORAL091182-001Feb 3, 2014AARXNoNo► Subscribe► Subscribe► Subscribe
Amneal Pharms Co
GLYCOPYRROLATE
glycopyrrolate
INJECTABLE;INJECTION208973-001Jun 15, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
GLYCOPYRROLATE
glycopyrrolate
TABLET;ORAL086900-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Express Scripts
US Department of Justice
Deloitte
Cerilliant
McKesson
Cantor Fitzgerald
Harvard Business School
Fuji
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot